Reproducibility Study of Overactive Bladder Symptom Score [OABSS]

A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China

NCT03572231 ·Status: COMPLETED

Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania

NCT03602508 ·Status: COMPLETED

A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication

NCT01317810 ·Status: WITHDRAWN

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

NCT02216214 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment

NCT01318837 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients

NCT00985387 ·Status: COMPLETED

A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)

NCT02386072 ·Status: COMPLETED

Predictors for Retreatement of OAB After DC Mirabegron

NCT04550702 ·Status: COMPLETED

Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome

NCT01503580 ·Status: COMPLETED ·Phase: NA

A Cross-sectional Internet Survey to Estimate Prevalence of Lower Urinary Tract Symptoms (LUTS)

NCT02618421 ·Status: COMPLETED

A Pilot Study Evaluating the Usability of the Oabi Mobile Application

NCT04534946 ·Status: COMPLETED

A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients

NCT00840645 ·Status: COMPLETED ·Phase: PHASE3

Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder Syndrome

NCT05040984 ·Status: UNKNOWN

Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects

NCT01029015 ·Status: COMPLETED

A Study of YM178 in Patients With Symptomatic Overactive Bladder

NCT00527033 ·Status: COMPLETED ·Phase: PHASE2

Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

NCT03044912 ·Status: UNKNOWN ·Phase: PHASE3

Treatment of the Overactive Bladder Syndrome: A Delphi Study

NCT04300400 ·Status: COMPLETED

Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.

NCT01093534 ·Status: COMPLETED ·Phase: PHASE4

Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.

NCT00658684 ·Status: COMPLETED ·Phase: PHASE3

Age-specific Prevalence and Comparisons of UDS and Bladder Diary Between OAB-wet and -Dry Women

NCT03807024 ·Status: COMPLETED

Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing

NCT03251300 ·Status: UNKNOWN ·Phase: PHASE4

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00688688 ·Status: COMPLETED ·Phase: PHASE3

Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

NCT03059134 ·Status: COMPLETED ·Phase: PHASE3

A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder

NCT00170755 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB)

NCT04545580 ·Status: COMPLETED ·Phase: PHASE2